Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New perspectives on depression]

I Gilaberte Asín1, T Huete Muñoz, B Boto Maldonado

  • 1Departamento de Investigación Médica Lilly, S.A.

Actas Luso-Espanolas De Neurologia, Psiquiatria Y Ciencias Afines
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Malignant neuroleptic syndrome: a review].

Archivos de neurobiologia·1986
Same author

[Neuroleptic malignant syndrome (N.M.S.). Presentation of a case treated with dantrolene].

Actas luso-espanolas de neurologia, psiquiatria y ciencias afines·1985
Same journal

[Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].

Actas luso-espanolas de neurologia, psiquiatria y ciencias afines·1999
Same journal

[Psychiatric symptoms in Cushing syndrome: a clinical case].

Actas luso-espanolas de neurologia, psiquiatria y ciencias afines·1999
Same journal

[Importance of the early diagnosis of malignant neuroleptic syndrome: report of 2 cases].

Actas luso-espanolas de neurologia, psiquiatria y ciencias afines·1999
Same journal

[Apolipoproteins and cognitive deterioration].

Actas luso-espanolas de neurologia, psiquiatria y ciencias afines·1999
Same journal

[Benzodiazepines in the treatment of schizophrenia: a review].

Actas luso-espanolas de neurologia, psiquiatria y ciencias afines·1999
Same journal

[Normative data for the neuropsychological evaluation of intravenous drug users].

Actas luso-espanolas de neurologia, psiquiatria y ciencias afines·1999
See all related articles

Depression is now viewed as a lifelong condition, not just episodic. Treatment guidelines now recommend a minimum of six months for episodes and prophylactic treatment to prevent future depressive episodes.

Area of Science:

  • Psychiatry and Mental Health
  • Neuroscience
  • Clinical Psychology

Context:

  • Historically, depression was viewed as episodic.
  • Current understanding recognizes depression as a longitudinal disorder.
  • This disorder can manifest episodically or chronically throughout a patient's life.

Purpose:

  • To update understanding of depression's nature.
  • To reflect changes in antidepressant treatment guidelines.
  • To emphasize long-term management strategies.

Summary:

  • Depression is increasingly understood as a longitudinal disorder, not solely episodic.
  • This paradigm shift influences current antidepressant treatment guidelines.
  • Minimum treatment duration for depressive episodes is now six months.

Related Experiment Videos

  • Prophylactic treatment is recommended for patients at high risk of recurrence to maintain mood stability.

    • Impact:

    • Revised treatment protocols for depression.
    • Emphasis on long-term management and prevention of recurrence.
    • Improved patient outcomes through sustained euthymic mood.